Search for: "WATSON PHARMACEUTICALSÂ "
Results 101 - 120
of 360
Sorted by Relevance
|
Sort by Date
22 Apr 2013, 5:34 am
Watson Pharmaceuticals, 2013 WL 1405226 (D.N.J.) [read post]
2 Dec 2011, 10:28 am
Watson Pharmaceuticals and Ranbaxy Laboratories both announced plans to distribute a generic version of atorvastatin containing the same active ingredients under its own brand. [read post]
30 Apr 2012, 9:37 pm
By Kevin E. [read post]
13 Mar 2013, 4:45 am
Companies Agree to Sell Rights to 18 Drugs to Satisfy FTCThe Federal Trade Commission will require Watson Pharmaceuticals, Inc. and Actavis Inc. to sell the rights and assets to 18 drugs to Sandoz International GmbH and Par Pharmaceuticals, Inc, and relinquish the manufacturing and marketing rights to three others, to settle charges that Watson’s proposed $5.9 billion acquisition of Actavis would otherwise be anticompetitive.... [read post]
15 Jan 2013, 11:33 am
Companies Agree to Sell Rights to 18 Drugs to Satisfy FTCThe Federal Trade Commission will require Watson Pharmaceuticals, Inc. and Actavis Inc. to sell the rights and assets to 18 drugs to Sandoz International GmbH and Par Pharmaceuticals, Inc, and relinquish the manufacturing and marketing rights to three others, to settle charges that Watson’s proposed $5.9 billion acquisition of Actavis would otherwise be anticompetitive.... [read post]
18 Apr 2016, 12:49 pm
The complaint also names Allergan plc, the parent company of Watson, and Endo International plc, the parent company of Endo Pharmaceuticals Inc. [read post]
16 Jun 2014, 8:04 am
Watson Laboratories, Inc. [read post]
18 Oct 2009, 5:42 pm
Judge Brown found that the patent in question, US Patent No. 5,565,473, was valid and enforceable, and [...]...FTC Sues Regarding AndroGel Patent Settlement The Federal Trade Commission has filed a complaint in federal district court challenging agreements in which Solvay Pharmaceuticals, Inc. paid generic drug makers Watson Pharmaceuticals, Inc. and Par Pharmaceutical Companies, Inc. to delay generic competition to Solvay’s branded… [read post]
25 Mar 2011, 8:29 pm
" Duramed Pharmaceuticals v. [read post]
17 Nov 2017, 11:00 am
Watson Labs.. [read post]
1 Apr 2016, 5:30 am
The FTC’s complaint alleges that Endo paid the first generic companies that filed for FDA approval – Impax Laboratories, Inc. and Watson Laboratories, Inc. [read post]
13 Feb 2012, 12:54 pm
Watson Laboratories, Inc., C.A. [read post]
11 Apr 2013, 4:57 am
FTC Sues Regarding AndroGel Patent SettlementThe Federal Trade Commission has filed a complaint in federal district court challenging agreements in which Solvay Pharmaceuticals, Inc. paid generic drug makers Watson Pharmaceuticals, Inc. and Par Pharmaceutical Companies, Inc. to delay generic competition to Solvay’s branded testosterone-replacement drug AndroGel, a prescription pharmaceutical with annual sales of more than $400 million. [read post]
5 Jan 2007, 9:49 pm
In response to the Federal Circuit's decision, Savient announced in a December 29 press release that Watson Pharmaceuticals has launched an A-B rated authorized generic of oxandrolone tablets. [read post]
12 Mar 2013, 6:40 am
Watson Pharmaceuticals, Inc., a case concerning reverse payment settlements of patent litigation. [read post]
26 May 2012, 8:41 pm
Back in March we wrote about a number of ongoing cases between original manufacturer AstraZeneca AB, and generic pharmaceutical companies Apotex Pty Ltd, Watson Pharma Pty Ltd and Ascent Pharma Pty Ltd, over cholesterol drug rosuvastatin, marketed in Australian by AstraZeneca as CRESTOR. [read post]
24 Aug 2011, 12:03 pm
Barr Pharmaceuticals settled a similar case last year and Watson/Schein Pharmaceuticals Inc. reportedly anticipates an imminent settlement. [read post]
9 Sep 2013, 4:09 am
Watson v. [read post]
27 Nov 2013, 6:00 am
Actavis, Inc., along with its wholly owned subsidiaries Actavis Pharma and Watson Laboratories, (collectively, "Actavis") are pharmaceutical companies that develop, manufacture, market and distribute generic pharmaceutical products for sale in the United States. [read post]
4 Sep 2012, 7:04 am
Watson Pharmaceuticals, Inc., No. 10-12729 (11th Cir. [read post]
